These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1737542)

  • 1. Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients.
    Selam JL; Raccah D; Jean-Didier N; Lozano JL; Waxman K; Charles MA
    Diabetes Care; 1992 Jan; 15(1):53-8. PubMed ID: 1737542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-benefit comparison of intensive diabetes management with implantable pumps versus multiple subcutaneous injections in patients with type I diabetes.
    Haardt MJ; Selam JL; Slama G; Bethoux JP; Dorange C; Mace B; Ramaniche ML; Bruzzo F
    Diabetes Care; 1994 Aug; 17(8):847-51. PubMed ID: 7956629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost benefits of intensive insulin therapy using injections, external pumps and implantable pumps].
    Selam JL; Haardt MJ; Berne C; Dorange C; Lanoe JL; Bethoux JP; Slama G
    Diabete Metab; 1993 Dec; 19(5 Suppl):506-9. PubMed ID: 8206188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous intraperitoneal insulin infusion versus subcutaneous insulin therapy in the treatment of type 1 diabetes: effects on glycemic variability.
    van Dijk PR; Groenier KH; DeVries JH; Gans RO; Kleefstra N; Bilo HJ; Logtenberg SJ
    Diabetes Technol Ther; 2015 Jun; 17(6):379-84. PubMed ID: 25856045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
    DeVries JH; Snoek FJ; Kostense PJ; Masurel N; Heine RJ;
    Diabetes Care; 2002 Nov; 25(11):2074-80. PubMed ID: 12401759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study.
    Jeandidier N; Pinget M; Keipes M; Louy S; Vetter A; Réville P
    Transplant Proc; 1992 Jun; 24(3):948-9. PubMed ID: 1604678
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial of programmable implantable insulin pump for type I diabetes.
    Selam JL; Micossi P; Dunn FL; Nathan DM
    Diabetes Care; 1992 Jul; 15(7):877-85. PubMed ID: 1516508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.
    Dunn FL; Nathan DM; Scavini M; Selam JL; Wingrove TG
    Diabetes Care; 1997 Jan; 20(1):59-63. PubMed ID: 9028695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
    Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
    Scarpioni L; Ballocchi S; Castelli A; Scarpioni R
    Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal versus subcutaneous insulin therapy in the treatment of type 1 diabetes mellitus.
    van Dijk PR; Logtenberg SJ; Hendriks SH; Groenier KH; Feenstra J; Pouwer F; Gans RO; Kleefstra N; Bilo HJ
    Neth J Med; 2015 Nov; 73(9):399-409. PubMed ID: 26582805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.
    Saudek CD; Duckworth WC; Giobbie-Hurder A; Henderson WG; Henry RR; Kelley DE; Edelman SV; Zieve FJ; Adler RA; Anderson JW; Anderson RJ; Hamilton BP; Donner TW; Kirkman MS; Morgan NA
    JAMA; 1996 Oct 23-30; 276(16):1322-7. PubMed ID: 8861991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps.
    Renard E; Lauton D; Bonifacj C; Costalat G; Jacques D; Bringer J; Jaffiol C
    Diabete Metab; 1993; 19(4):364-71. PubMed ID: 8293863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study.
    Maiorino MI; Bellastella G; Casciano O; Cirillo P; Simeon V; Chiodini P; Petrizzo M; Gicchino M; Romano O; Caruso P; Giugliano D; Esposito K
    Diabetes Technol Ther; 2018 Feb; 20(2):117-126. PubMed ID: 29303370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
    Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
    Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of severe brittle diabetes with "Infusaid" implantable pumps.
    Gill GV; Husband DJ; Wright PD; Sharpe G; Taylor R; Walford S; Marshall SM; Alberti KG
    Diabetes Res; 1986 Mar; 3(3):135-7. PubMed ID: 3709039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of programmable implantable insulin delivery systems.
    Olsen CL; Liu G; Iravani M; Nguyen S; Khourdadjian K; Turner DS; Waxman K; Selam JL; Charles MA
    Int J Artif Organs; 1993 Dec; 16(12):847-54. PubMed ID: 8175202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial.
    Logtenberg SJ; Kleefstra N; Houweling ST; Groenier KH; Gans RO; van Ballegooie E; Bilo HJ
    Diabetes Care; 2009 Aug; 32(8):1372-7. PubMed ID: 19429874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society.
    Broussolle C; Jeandidier N; Hanaire-Broutin H
    Lancet; 1994 Feb; 343(8896):514-5. PubMed ID: 7906761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.
    Weintrob N; Benzaquen H; Galatzer A; Shalitin S; Lazar L; Fayman G; Lilos P; Dickerman Z; Phillip M
    Pediatrics; 2003 Sep; 112(3 Pt 1):559-64. PubMed ID: 12949284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.